Morgan Stanley’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3 | Hold |
9
| – | – | ﹤0.01% | 8060 |
|
|
2025
Q1 | $6 | Hold |
9
| – | – | ﹤0.01% | 8022 |
|
|
2024
Q4 | $9 | Sell |
9
-300
| -97% | -$300 | ﹤0.01% | 7912 |
|
|
2024
Q3 | $309 | Buy |
309
+270
| +692% | +$270 | ﹤0.01% | 7347 |
|
|
2024
Q2 | $45 | Buy |
39
+24
| +160% | +$28 | ﹤0.01% | 7527 |
|
|
2024
Q1 | $20 | Sell |
15
-3
| -17% | -$4 | ﹤0.01% | 7720 |
|
|
2023
Q4 | $34 | Sell |
18
-3
| -14% | -$6 | ﹤0.01% | 7723 |
|
|
2023
Q3 | $58 | Hold |
21
| – | – | ﹤0.01% | 7479 |
|
|
2023
Q2 | $111 | Hold |
21
| – | – | ﹤0.01% | 7488 |
|
|
2023
Q1 | $187 | Sell |
21
-2
| -9% | -$18 | ﹤0.01% | 7521 |
|
|
2022
Q4 | $124 | Sell |
23
-18
| -44% | -$97 | ﹤0.01% | 7681 |
|
|
2022
Q3 | $0 | Buy |
41
+20
| +95% | – | ﹤0.01% | 7678 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 7651 |
|
|
2022
Q1 | $1K | Sell |
21
-1
| -5% | -$48 | ﹤0.01% | 7817 |
|
|
2021
Q4 | $1K | Sell |
22
-1,587
| -99% | -$72.1K | ﹤0.01% | 7841 |
|
|
2021
Q3 | $173K | Buy |
1,609
+1,588
| +7,562% | +$171K | ﹤0.01% | 6076 |
|
|
2021
Q2 | $1K | Sell |
21
-187
| -90% | -$8.91K | ﹤0.01% | 7581 |
|
|
2021
Q1 | $13K | Buy |
208
+187
| +890% | +$11.7K | ﹤0.01% | 6861 |
|
|
2020
Q4 | $1K | Hold |
21
| – | – | ﹤0.01% | 6929 |
|
|
2020
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 6636 |
|
|
2020
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 6507 |
|
|
2020
Q1 | $1K | Hold |
21
| – | – | ﹤0.01% | 6443 |
|
|
2019
Q4 | $1K | Hold |
21
| – | – | ﹤0.01% | 6548 |
|
|
2019
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 6527 |
|
|
2019
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 6511 |
|
|
2019
Q1 | $2K | Sell |
21
-1
| -5% | -$95 | ﹤0.01% | 6439 |
|
|
2018
Q4 | $3K | Buy |
22
+1
| +5% | +$136 | ﹤0.01% | 6365 |
|
|
2018
Q3 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 6607 |
|